Brain, Mind, and Neurofeedback: The Next 100 Years
Archives
All entries, chronologically...
Psychological interventions to prevent depression in children and adolescents can be useful and with protective effects that last for up to a year, finds a new systematic review. According to research cited in the new review, in 2002, depression ranked second greatest cause of disability in developed countries and first in many developing ones. The review appears in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research.
This study suggests an innovative psychological treatment called ‘concreteness training’ can reduce depression in just two months and could work as a self-help therapy for depression in primary care. Led by the University of Exeter and funded by the Medical Research Council, the research shows how this new treatment could help some of the 3.5 million people in the UK living with depression.
A recent trial shows cognitive-behavioral therapy (CBT) reduces functional disability and depressive symptoms in adolescents with juvenile fibromyalgia. The psychological intervention was found to be safe and effective, and proved to be superior to disease management education. Full findings from this multi-site clinical trial are published in Arthritis & Rheumatism, a peer-reviewed journal of the American College of Rheumatology (ACR).
Family caregivers of people with dementia experience more burden and are at greater risk of developing depression than caregivers of people with a chronic illness. A new evidence review from the Netherlands finds that a psychotherapy technique called cognitive reframing can help reduce caregivers’ stress when they are caring for loved ones with dementia.
Psychotherapy has come a long way since the days of Freudian psychoanalysis – today, rigorous scientific studies are providing evidence for the kinds of psychotherapies that effectively treat various psychiatric disorders. But Alan Kazdin, the John M. Musser Professor of Psychology at Yale University, believes that we must acknowledge a basic truth – all of our progress and development in evidence-based psychotherapy has failed to solve the rather serious problem of mental illness in the United States.
Three randomized controlled trials published Online First today in Archives of Internal Medicine examine the effectiveness of behavioral and educational interventions for patients with poorly controlled diabetes. All three reports are part of the journal’s Health Care Reform series.
Cognitive therapy has dynamically improved the most neurologically impaired, poorly functioning schizophrenic patients. For the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania have shown that a psychosocial treatment can significantly improve daily functioning and quality of life in the lowest-functioning cases of schizophrenia. The study appears in the October 3 edition of Archives of General Psychiatry.
Prolonged exposure therapy, cognitive therapy, and delayed prolonged exposure therapy, appear to reduce posttraumatic stress disorder symptoms in patients who have experienced a recent traumatic event, according to a report published Online First by Archives of General Psychiatry, one of the JAMA/Archives journals. The study was conducted by Arieh Y. Shalev, M.D., and colleagues from Hadassah University Hospital, Jerusalem, Israel.
Children and teens with obsessive-compulsive disorder (OCD) who were receiving some benefit from treatment with medication had a significantly greater reduction in OCD symptoms with the addition of cognitive behavior therapy (CBT), according to a study in the September 21 issue of JAMA. The study was carried out by Martin E. Franklin, Ph.D., of the University of Pennsylvania School of Medicine, Philadelphia, and colleagues.
About half of Medicaid-covered children and adolescents in Ohio who are in treatment for depression complete their first three months of prescribed antidepressants, and only one-fifth complete the recommended minimum six-month course of drugs to treat depression, new research suggests. Among those at the highest risk for not completing treatment are adolescents – as opposed to younger children – and minority youths, particularly African Americans, according to the analysis of Medicaid prescription data over a three-year period.
